RT Book, Section
A1 Bernstein, David
A2 Molmenti, Ernesto Pompeo
A2 Santibañes, Martin de
A2 Santibañes, Eduardo de
SR Print(0)
ID 1180107460
T1 Treatment of Hepatitis C before and after Transplantation
T2 Liver Transplantation: Operative Techniques and Medical Management
YR 2021
FD 2021
PB McGraw Hill
PP New York, NY
SN 9781260462517
LK accesssurgery.mhmedical.com/content.aspx?aid=1180107460
RD 2024/04/20
AB Hepatitis  C  is  the  most  common  cause  of  chronic  hepatitis  C  in  the  United  States,  affecting  an  estimated  2.4  million  people,  most  of  whom  have  not  yet  been  identified.1  Cirrhosis  as  a  result  of  hepatitis  C  infection  is  a  common  indication  for  liver  transplantation  and  is  a  major  predisposing  factor  for  the  development  of  primary  hepatocellular  carcinoma  in  the  United  States.2,3  Risk  factors  for  progression  to  cirrhosis  in  hepatitis  C  infection  include  male  sex,  age  greater  than  50  years,  alcohol  use,  the  presence  of  nonalcoholic  fatty  liver  disease,  hepatitis  B  virus  (HBV)  and  HIV  co-infection,  and  immunosuppressive  therapy.4,5